Price Alert

Oncology Institute Inc. (TOI)

NASDAQ: TOI · Real-Time Price · USD

4.01

0.02 (0.50%)

At close: Oct 15, 2025, 3:59 PM

4.01

0.00%

After-hours: Oct 15, 2025, 04:10 PM EDT

0.50% (1D)

Bid	3.9
Market Cap	374.91M
Revenue (ttm)	424.38M
Net Income (ttm)	-65.89M
EPS (ttm)	-0.67
PE Ratio (ttm)	-5.99
Forward PE	-13.62
Analyst	Buy
Dividends	n/a

Ask	4.05
Volume	2,190,507
Avg. Volume (20D)	1,813,123
Open	4.02
Previous Close	3.99
Day's Range	3.93 - 4.19
52-Week Range	0.13 - 4.50
Beta	0.11
Ex-Dividend Date	n/a

About TOI

undefined

[Read more]

Industry n/a

Sector n/a

IPO Date n/a

Employees NaN

Stock Exchange n/a

Ticker Symbol TOI

Website n/a

Full Company Profile

Analyst Forecast

According to 0 analyst ratings, the average rating for TOI stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

Stock Forecasts

Next Earnings Release

Oncology Institute Inc. is scheduled to release its earnings on Nov 12, 2025, after market closes.
Analysts project revenue of ... Unlock content with Pro Subscription

Why Price Moved

2 months ago

-10.49%

The Oncology Institute shares are trading lower af... Unlock content with Pro Subscription

5 months ago

+28.27%

The Oncology Institute shares are trading higher after the company reported a year-over-year increase in Q1 financial results.

News

1 week ago · investors.com

Small Stocks Shoot Higher — Here Are 7 Up The Most

Big-cap stocks like Nvidia and Palantir steal attention. But now investors are scoring gains on small caps not in the S&P 500.

3 weeks ago · seekingalpha.com

Topicus: Rising To The Topicus Of VMS Supremacy In Europe

Topicus.com Inc. (TOI:CA) is a leading European vertical market software acquirer, benefiting from a fragmented European market and low Private Equity competition. TOI's record acquisition spending in...

3 weeks ago · zacks.com

The Oncology Institute (TOI) Loses 20% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner

The Oncology Institute (TOI) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnin...

1 month ago · seekingalpha.com

The Oncology Institute: A Promising Company In A Growing Sector

The Oncology Institute has achieved a strong growth in revenue in the previous years, justifying its stock price movement. We believe TOI will still be able to grow in the coming quarters while curren...

2 months ago · seekingalpha.com

The Oncology Institute, Inc. (TOI) Q2 2025 Earnings Call Transcript

The Oncology Institute, Inc. (NASDAQ:TOI ) Q2 2025 Earnings Conference Call August 13, 2025 5:00 PM ET Company Participants Daniel Virnich - CEO & Executive Director Mark Hueppelsheuser - Corporate Pa...